CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation

J. D. Marra, E. Galli, S. Giammarco, E. Metafuni, G. Minnella, F. Fosso, S. Marietti, Simona Sica, Federica Sora', Patrizia Chiusolo*

*Corresponding author

Research output: Contribution to journalArticle

Abstract

While there is intense interest in the production of allogeneic CAR-T cells from umbilical cord units, little is known about the reactivity and persistence of CAR-T cells of umbilical origin. We report the case of a patient at our hematological center with multiple relapsing Ph+ B-ALL, notably a Blinatunomab non-responder, who underwent therapy with Brexucabtagene Autoleucel following relapse on Ponatinib post-allogeneic hematopoietic stem cell transplantation. The patient achieved a rapid CAR-T expansion and durable remission presenting in good clinical conditions 6 months post-CAR-T infusion, without manifestations of graft-versus-host disease. The case report provides insight into the reactivity and persistence of CAR-T cells of umbilical origin, confirming the potential promise of allogeneic umbilical cord-derived CAR-T cells.
Original languageEnglish
Pages (from-to)127-129
Number of pages3
JournalEuropean Journal of Haematology
Volume113
Issue number1
DOIs
Publication statusPublished - 2024

All Science Journal Classification (ASJC) codes

  • Hematology

Keywords

  • CAR-T
  • acute lymphoblastic leukemia
  • cord blood transplantation

Fingerprint

Dive into the research topics of 'CAR-T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

Cite this